Transferrin-bearing dendrimers for cancer therapy: An update

Nanomedicine

Volumn 10, Issue 14, 2015, Pages 2125-2127

  Somani, Sukrut ^a   Dufès, Christine ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

dendrimer; gene therapy; nanomedicine; transferrin; tumor targeting

Indexed keywords

DENDRIMER; DOXORUBICIN; POLYAMIDOAMINE; TRANSFERRIN; TRANSFERRIN RECEPTOR;

BLOOD BRAIN BARRIER; CANCER CELL; CANCER INHIBITION; CANCER THERAPY; DRUG DELIVERY SYSTEM; EDITORIAL; GENE THERAPY; HUMAN; MOLECULARLY TARGETED THERAPY; NANOMEDICINE; NONHUMAN; PRIORITY JOURNAL; CHEMISTRY; NEOPLASMS; PROCEDURES;

DENDRIMERS; HUMANS; NANOMEDICINE; NEOPLASMS; TRANSFERRIN;

EID: 84938375680     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.15.93     Document Type: Editorial

References (22)

1. Huebers HA, Finch CA. The physiology of transferrin and transferrin receptors. Physiol. Rev. 67, 520-582 (1987)
2. Brandsma ME, Jevnikar AM, Ma S. Recombinant human transferrin: beyond iron binding and transport. Biotechnol. Adv. 29, 230-238 (2011)
3. Yang DC, Wang F, Elliott RL, Head JF. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer. Anticancer Res. 21, 541-549 (2001)
4. Seymour GJ, Walsh MD, Lavin MF, Strutton G, Gardiner RA. Transferrin receptor expression by human bladder transitional cell carcinomas. Urol. Res. 15, 341-344 (1987)
5. Kondo K, Noguchi M, Mukai K et al. Transferrin receptor expression in adenocarcinoma of the lung as a histopathologic indicator of prognosis. Chest 97, 1367-1371 (1990)
6. Kawabata H, Germain RS, Vuong PT, Nakamaki T, Said JW, Koeffler HP. Transferrin receptor 2-alpha supports cell growth in iron-chelated cultured cells and in vivo. J. Biol. Chem. 275, 16618-16625 (2000)
7. Tomalia DA, Baker H, Dewald J et al. A new class of polymers: starburst-dendritic macromolecules. Polym. J. 17, 117-132 (1985)
8. Buhleier E, Wehner W, Vögtle F. Cascade nonskid-chain-like syntheses of molecular cavity topologies. Synthesis 2, 155-158 (1978)
9. Newkome GR, Yao ZQ, Baker GR, Gupta VK. Micelles: 1. Cascade molecules: a new approach to micelles: a [27]-arborol. J. Org. Chem. 50, 2003-2004 (1985)
10. Hawker CJ, Fréchet JMJ. Preparation of polymers with controlled molecular architecture: a new convergent approach to dendritic macromolecules. J. Am. Chem. Soc. 112, 7638-7647 (1990)
11. Liu M, Fréchet JMJ. Designing dendrimers for drug delivery. Pharm. Sci. Technol. Today 2, 393-401 (1999)
12. Han L, Huang R, Li J, Liu S, Huang S, Jiang C. Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer. Biomaterials 32, 1242-1252 (2011)
13. Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, Mason DY. Transferrin receptor on endothelium of brain capillaries. Nature 312, 162-163 (1984)
14. He H, Li Y, Jia XR et al. PEGylated poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors. Biomaterials 32, 478-487 (2011)
15. Li Y, He H, Jia X, Lu WL, Lou J, Wei Y. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. Biomaterials 33, 3899-3908 (2012)
16. Kabanov VA, Zezin AB, Rogacheva VB et al. Polyelectrolyte behavior of astramol poly(propyleneimine) dendrimers. Macromolecules 31, 5142-5144 (1998)
17. Koppu S, Oh YJ, Edrada-Ebel R et al. Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA. J. Control. Release 143, 215-221 (2010)
18. Al Robaian M, Chiam KY, Blatchford DR, Dufès C. Therapeutic efficacy of intravenously administered transferrin-conjugated dendriplexes on prostate carcinomas. Nanomedicine 9, 421-434 (2014)
19. Lemarié F, Croft DR, Tate RJ, Ryan KM, Dufès C. Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system. Biomaterials 33, 2701-2709 (2012)
20. Zhou Y, Zeng Z, Zhang W et al. Lactotransferrin: a candidate tumor suppressor-deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int. J. Cancer 123, 2065-2072 (2008)
21. Lim LY, Koh PY, Somani S et al. Tumor regression following intravenous administration of lactoferrin-and lactoferricinbearing dendriplexes. Nanomedicine 11, 1445-1454 (2015)
22. Kawabata H, Germain RS, Vuong PT, Nakamaki T, Said JW, Koeffler HP. Transferrin receptor 2-alpha supports cell growth in iron-chelated cultured cells and in vivo. J. Biol. Chem. 275, 16618-16625 (2000).